53.07 USD
▲+1.58+7.06%
盘后 50.21 +1.29%
2026-08-03
市值
$5.23B
市盈率
—
EPS
-4.76
股息率
—
52 周区间
44.12 – 78.48
成交量
2.14M
Beta
1.74
目标价
86.78
52W 低 44.1252W 高 78.48
价格走势
公司简介
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company’s CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as deve...